Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pharmacy benefit managers inflated drug prices by $7.3B
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,
FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain
Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments
Hosted on MSN
36m
Brian Thompson's boss: Pharma companies are "really responsible" for drug prices
The CEO of the company whose insurance leader was killed in New York pledged to help fix the health care industry while also ...
1d
on MSN
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
2d
Drugmakers hiked prices for hundreds of drugs in early January
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
39m
on MSN
Columbus joins national fight accusing drug manufacturers of inflating insulin prices
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
6d
Drug company job cuts surged last year, and this year is starting with more
The job cuts reflect the normal maturation of companies such as Alameda-based Scribe, which is moving from a preclinical to ...
1d
How a Company Makes Millions Off a Hospital Program Meant to Help the Poor
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big ...
Modern Healthcare
8h
DEA drug prescribing proposal may change providers' strategies
Telehealth companies aren't sure if the Trump administration will finalize the Biden administration's proposal around remote ...
21h
Regulator accuses drug middlemen of wild price hikes, possibly steering business to themselves
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
9d
Drug Company to Share Revenues With Indigenous People Who Donated Their Genes
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...
El País in English
2h
AI creates for the first time a treatment for a disease forgotten by pharmaceutical companies
The laboratory of the latest Nobel Prize winner in Chemistry David Baker, headed by researcher Susana Vázquez, talks about ‘democratizing’ the discovery of therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback